Circulation. 2008;118:586–606.PubMedCrossRef 2. American College of Cardiography Foundation Task Force on Expert Consensus Documents, Mark DB, Berman DS, Budoff MJ, et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on
Expert Consensus Documents. Circulation. 2010;121:2509–43.PubMedCrossRef Adriamycin nmr 3. Mollet NR, Cademartiri F, van Mieghem CA, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005;112:2318–23.PubMedCrossRef 4. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324–36.PubMedCrossRef 5. Ropers U, Ropers D, Pflederer T, et al. Influence of heart rate on the diagnostic accuracy of dual-source computed tomography coronary angiography. J Am Coll Cardiol. 2007;50:2393–8.PubMedCrossRef 6. Husmann L, Valenta I, Gaemperil O, et al. Feasibility of low-dose coronary CT angiography: first experience with
prospective ECG-gating. Eur Heart J. 2008;29:191–7.PubMedCrossRef 7. Hausleiter J, Meyer T, Hermann F, et al. Estimated radiation dose associated with cardiac CT angiography. JAMA. 2009;301:500–7.PubMedCrossRef 8. Nakashima M, Kanemaru M. Phase I study of ONO-1101, a new ultra short acting b1-blocking agent in healthy volunteers [in Japanese]. J Clin Cytoskeletal Signaling inhibitor Ther Med. 2000;16:1531–56. 9. Hirano M, Hara K, Ikari Y, Jinzaki M, Iino M, Hamada C, Kuribayashi S. Dose-finding study of landiolol hydrochloride: a short-acting β1-blocker for controlling heart rate during coronary computed-tomography angiography
in Japan. Adv Ther. 2013;30:803–18.PubMedCentralPubMedCrossRef 10. Jinzaki M, Hirano M, Hara K, Suzuki T, Yamashina A, Ikari Y, et al. A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected click here ischemic cardiac disease. Int J Cardiovasc Imaging. 2013;29:7–20.PubMedCentralPubMedCrossRef 11. Hirano M, Yamashina A, Hara K, Ikari Y, Jinzaki M, Iino M, et al.; Landiolol check Hydrochloride Study Group. A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease. Clin Drug Investig. 2014;34:53–62. 12. Isobe S, Sato K, Sugiura K, Mimura T, Kobayashi M, Meno C, et al. Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience. Circ J. 2008;72:1814–20.PubMedCrossRef 13. Osawa K, Miyoshi T, Sato S, Akagi N, Morimitsu Y, Nakamura K, et al.